Vislink Technologies Closes $4,000,000 Public Offering
HACKETTSTOWN, NJ, Nov. 27, 2019 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (“Vislink” or the “Company”) (NASDAQ: VISL) announced today that […]
Reebonz Hypes It Up In A Race For Black Friday
SINGAPORE, Nov. 27, 2019 (GLOBE NEWSWIRE) — Reebonz Holding Limited (NASDAQ: RBZ), a leading online luxury marketplace and platform in […]
VMware to Present at the Barclays Global Technology, Media and Telecommunications Conference
PALO ALTO, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) — VMware, Inc. (NYSE: VMW), a leading innovator in enterprise software, today […]
Quanex Building Products Announces Fourth Quarter and Fiscal Year 2019 Earnings Release and Conference Call Schedule
HOUSTON, TEXAS, Nov. 27, 2019 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced […]
AssetMark to Attend the Goldman Sachs Financial Services Conference
CONCORD, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) — AssetMark Financial Holdings, Inc. (NYSE: AMK) today announced that the Company will […]
Lilis Energy Notified of NYSE American Listing Deficiency
FORT WORTH, Texas, Nov. 27, 2019 (GLOBE NEWSWIRE) — Lilis Energy, Inc. (NYSE American: LLEX) (the “Company”), an exploration and […]
Compass Diversified Holdings to Present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference
WESTPORT, Conn., Nov. 27, 2019 (GLOBE NEWSWIRE) — Compass Diversified Holdings (NYSE: CODI) (“CODI” or the “Company”), an owner of […]
Kezar Life Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) — Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering […]
AutoZone to Release First Quarter Earnings December 10, 2019
MEMPHIS, Tenn., Nov. 27, 2019 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE:AZO), the nation’s leading auto parts retailer and a leading […]
Fate Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
SAN DIEGO, Nov. 27, 2019 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the […]
